PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Share News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.75
Bid: 3.70
Ask: 3.80
Change: -0.10 (-2.60%)
Spread: 0.10 (2.703%)
Open: 3.85
High: 3.85
Low: 3.65
Prev. Close: 3.85
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Strong trading from Shoe Zone, Fulham Shore

Wed, 31st Aug 2022 16:07

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Polarean Imaging PLC - London-based medical‑imaging technology - For the first half of 2022, pretax loss widens to USD6.9 million from USD4.9 million, due to rising costs from supporting the resubmission of a new drug application and the building of infrastructure to support launching products, more than offsetting a 34% increase in revenue to USD834,087 from USD621,874 from the sale of polariser systems to McMaster University in Ontario, Canada and Cincinnati Children's Medical Center.

----------

Shoe Zone PLC - Leicester, England-based footwear retailer - Since late July, trading exceeds expectations on strong demand for summer and back to school products in August. As a result, adjusted pretax profit for the year ending October 2 is set to be at least GBP10.5 million, up from GBP9.5 million the year before.

----------

Fulham Shore PLC - owner of the Franco Manca restaurant chain - Trading for the company's financial year to date, remains in line with management expectations, despite turmoil in the UK economy, as well as train and tube strikes. Over the year, opens nine Franco Mancas, and one The Real Greek, bringing its total restaurant estate to 90. Remains on-track to deliver 18 new restaurants in the current financial year ending March 2023.

----------

Flowtech Fluidpower PLC - supplier of technical fluid power products - For the six months ended June 30, pretax profit rises 35% to GBP3.1 million from GBP2.3 million the same period a year before, on revenue which grows 3.9% year-on-year to GBP57.5 million from GBP55.3 million, as the Flowtech business rose in strong pricing, while the Fluidpower businesses grew on a stronger hydraulics market. Looking ahead, company says its visibility for the Flowtech business behind the short term is limited, and as a result will focus on monitoring short term demand variations.

----------

Clarify Pharma PLC - London-based investor in psychedelics companies - For the six months ended May 31, pretax loss narrows to GBP297,169 from GBP472,748 the same period a year before, mainly due to lower administrative costs. Cash position stands at GBP1.2 million at the end of May, as the company continues to look for opportunities in the psychedelics market.

----------

GRC International Group PLC - Ely, England-based provider of products and services for IT governance, risk management and compliance - For the year ended March 31, pretax loss narrows to GBP1.0 million from GBP2.2 million, on revenue which grows 18% year-on-year to GBP13.9 million from GBP11.8 million, as billings rise 20% to GBP14.8 million from GBP12.3 million. Looking ahead, GRC notes strong momentum has continued into the first five months of its current financial year, as trading remains in line with expectations.

----------

Alba Mineral Resources PLC - mineral exploration company focused on northern Europe - For the six months ended May 31, pretax loss widens to GBP815,000 from GBP568,000 the same period a year prior, due to higher costs due to there being a second AIM-listed entity within the group during the period. Looking ahead, Alba says it is in a strong position to generate growth across its portfolio of assets.

----------

James Latham PLC - Hertfordshire-based distributor of timber, panels and decorative surfaces - For the fourth four months of its current financial year from April 1 to July 31, stands at GBP142 million. " This represents an increase in sales per working day of 15% compared with the same period last year," company adds. This is due to stable prices more than offsetting a slight drop in volumes. Although customers remain busy, James Latham notes signs of weakness in some sectors, including inflation, reduced consumer confidence and higher interest rates being reasons for dampening demand.

----------

Plaza Centers NV - property investor in India - For the first half of 2022, pretax loss narrows to EUR6.3 million from EUR8.9 million the same period a year before, as a result of lower costs across the board, and an increase in revenue to EUR146,000 from EUR125,000 year-on-year. Mainly, there is a drop in finance costs due to a foreign currency gain on bonds.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
18 Oct 2019 09:44

Amphion Has No Obligations To Lender After Polarean Stake Sale

Amphion Has No Obligations To Lender After Polarean Stake Sale

Read more
11 Oct 2019 18:54

DIRECTOR DEALINGS: Polarean Imaging Non Exec Buys GBP200,000 In Shares

DIRECTOR DEALINGS: Polarean Imaging Non Exec Buys GBP200,000 In Shares

Read more
11 Oct 2019 10:49

Amphion Innovations Disappointed At Having To Sell Polarean Shares

Amphion Innovations Disappointed At Having To Sell Polarean Shares

Read more
3 Oct 2019 12:11

Amphion Sells USD2.3 Million In Polarean Shares To Repay Debt

Amphion Sells USD2.3 Million In Polarean Shares To Repay Debt

Read more
25 Sep 2019 12:30

Amphion Innovations Looking For More Options As It Extends Loan

Amphion Innovations Looking For More Options As It Extends Loan

Read more
24 Sep 2019 11:24

Polarean Imaging Interim Loss Deepens On Polariser Sales Timing

Polarean Imaging Interim Loss Deepens On Polariser Sales Timing

Read more
10 Sep 2019 17:29

Amphion Innovations Sells 1.2 Million Shares In Polarean Imaging

(Alliance News) - Amphion Innovations PLC said on Tuesday it has sold 1.2 million shares in partner company Polarean Imaging PLC.The sale generated total proceeds of USD313,127 for Amphion,

Read more
9 Aug 2019 16:38

Amphion Sells Polarean Imaging Shares To Reduce Loan Balance

(Alliance News) - Amphion Innovations PLC said Friday it has sold part of its stake in Polarean Imaging PLC in order to partly repay its loan facility.The medical and life science developer

Read more
5 Aug 2019 12:05

Polarean Enrols First Patient At University Of Cincinnati Trial Site

(Alliance News) - Polarean Imaging PLC on Monday announced enrolment of the first patients in its third trial site at the University of Cincinnati in the US and is on track for its third quarter a

Read more
27 Jun 2019 11:57

Polarean Loss Widens On Expenses As Firm Moves Toward Phase 3 Trials

(Alliance News) - Polarean Imaging PLC on Thursday posted a widened annual loss on administrative expenses as it works to start phase three clinical trials of its technology.Shares in were

Read more
27 Jun 2019 10:02

Polarean Imaging revenues climb as clinical trial nears completion

(Sharecast News) - Polarean Imaging's shares climbed on Thursday after reporting that its annual revenues doubled to come in slightly above expectations as sales in the US soared.

Read more
12 Jun 2019 18:16

Amphion Innovations To Work With Debt Providers To Refinance Facility

(Alliance News) - Amphion Innovations PLC said Wednesday its debt providers have told the company the excess value of the collateral does not meet the terms of an agreed facility between the in at

Read more
5 Jun 2019 12:35

Polarean Imaging Secures Polariser Unit Order From Canadian Hospital

LONDON (Alliance News) - Medical imaging technology firm Polarean Imaging PLC said Wednesday it has received a research unit order from a Canadian hospital.Polarean explained the Hospital a

Read more
21 May 2019 12:23

Polarean Imaging Confirms USD1 Million Cystic Fibrosis Trial Grant

LONDON (Alliance News) - Polarean Imaging PLC said Tuesday it had its third USD1 million tranche of a study grant confirmed for its late stage trial of xenon medical imaging for children being for

Read more
13 May 2019 10:44

Polarean Imaging Progresses On Clinical Trials, To Add New Trial Site

LONDON (Alliance News) - Polarean Imaging PLC on Monday said that it is progressing on its phase III clinical trials and plans to add an extra site in its lung resection pathway trial to improve a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.